Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plasma Sampling for In Vitro Lenvatinib Protein Binding
NCT02998775Phase 1Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Dec 2016
- Primary completion
- Jul 2017
- Countries
- 1
01
Overview
Phase 1, open-label trial (8 arms), sponsored by Eisai Co., Ltd. Primary endpoint: Number of participants with any serious adverse event and any non-serious adverse event at 1 week. Started Dec 2016; status: completed.
Beyond the preview
Go deeper on NCT02998775.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02998775.